haku: @indexterm aids / yhteensä: 45
viitteet: 1-10 / 45
« edellinen sivu | seuraava sivu »
 otsikkovuositekijä
1.
The AIDS epidemic: challenges for feminist economics
Feminist economics
2008 : OCT, VOL. 14:4, p. 1-18
 2008 Conrad, C.
Ross, C.R.
2.
"AIDS is not a business": A study in global corporate responsibility - Securing access to low-cost HIV medications
Journal of Business Ethics
2007 : JUN (II), VOL. 73:1, p. 65-75
 2007 Flanagan, W.
Whiteman, G.
3.
Patent rights or patent wrongs? The case of patent rights on AIDS drugs
Business Ethics
2006 : JUL, VOL 15:3, p. 299-305
 2006 Byrne, S. (et al.)
4.
Is there a morally right price for anti-retroviral drugs in the developing world?
Business Ethics
2006 : JAN, VOL 15:1, p. 29-43
 2006 Brennan, R.
Baines, P.
5.
Intellectual property and the pharmaceutical industry: a moral crossroads between health and property
Journal of Business Ethics
2004 : DEC II, VOL 55:3, p. 295-308
 2004 Gewertz, N. M.
Amado, R.
6.
Modelling Audit Risk Assessments: Exploration of an Alternative to the Use of Knowledge-based Systems
International Journal of Auditing
2003 : MAR, VOL. 7:1, p. 21-36
 2003 Lloyd, P.
Goldschmidt, P.
7.
AIDS and community-based organizations: the marketing of therapeutic discourse
European Journal of Marketing
2002 : VOL. 36:5-6, p. 621-641
 2002 Kates, S. M.
8.
Technology: Compulsory licensing of pharmaceuticals won't rid the world of infectious diseases
Economic Affairs
2001 : SEP, VOL. 21:3, p. 55-55
 2001 Morris, J.
9.
Framing Effects in Risk Perceptions of AIDS
Marketing Letters
2001 : VOL. 12:2, p. 145-156
 2001 Raghubir, P.
Menon, G.
10.
Methadone maintenance and HIV prevention: a cost-effectiveness analysis
Management Science
2000 : AUG, VOL. 46:8, p. 1013-1031
 2000 Zaric, G. S.
Brandeau, M. L.
Barnett, P. G.
« edellinen sivu | seuraava sivu »
SCIMA